Treace Medical Concepts Reports First Quarter 2022 Financial Results
May 05, 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Peer-Reviewed Publication of ALIGN3D™ Multicenter Prospective Clinical Data
May 05, 2022 08:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Secures Up to $150 Million in Debt Financing
May 02, 2022 08:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical...
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
April 14, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a paradigm shift in the surgical treatment of...
Treace Files Patent Infringement Suit To Protect Lapiplasty® Bunion Technology
March 28, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results
March 03, 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., March 03, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a paradigm shift in the...
Treace Announces Updated ALIGN3D™ Data at the 2022 ACFAS Scientific Conference
February 25, 2022 12:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference
February 23, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
February 14, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace to Announce Latest ALIGN3D™ Data at the 2022 ACFAS Scientific Conference
February 01, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...